Bharti Airtel, Hindalco Industries, Biocon in focus

28 Feb 2022 , 08:46 AM

Bharti Airtel: The telecom major on Friday said it has entered into an agreement with Vodafone Group Plc. to buy 4.7% equity in Indus Towers. The financial details of the deal have not been disclosed.

Hindalco Industries: The company has entered into a Share Purchase Agreement (SPA) with Terrabel Empreedimentos Ltda , a Brazilian firm to divest entire equity shareholding in Hindalco Do Brazil Industria Comercia de Alumina LTDA (HDB) – Wholly owned step down subsidiary of Hindalco Industries.

Biocon: Biocon Biologics, a subsidiary of Biocon, announced that it has entered into a definitive agreement with its partner Viatris Inc.. Accordingly, Biocon Biologics will acquire Viatris biosimilars business to create a unique fully integrated global biosimilars enterprise.

IRCON International: The company has been appointed as project implementation agency for a road project in Myanmar by Ministry of External Affairs (MEA), Government of India.

Clariant Chemicals: Clariant Chemicals on Friday announced that companys chief financial officer Ashish Agarwal tendered his resignation with effect from 20 April 2022.

Fortis Healthcare: CRISIL Ratings has upgraded its ratings on the bank facilities of the company to CRISIL AA-/CRISIL A1+ from CRISIL A+/CRISIL A1.

ITI: Brickwork Ratings has reaffirmed its ratings on the enhanced bank loan facilities of the company of Rs 4,469.50 crore. The fund-based long-term rating has been reaffirmed at BWR A- (CE)/ Stable while the non-fund based short term rating has been reaffirmed at BWR A2+ (CE).

Swiss Military Consumer Goods: The companys board approved raising upto Rs 50 crore through rights issue of the equity shares.

Yasho Industries: The company has acquired a 42.14-acre land at Pakhajan Village in Bharuch, Gujarat for future expansion of the manufacturing plant.

Rain Industries: The company posted a consolidated net loss of Rs 97 crore in Q4 December 2021 as compared to a net profit of Rs 307 crore registered in Q4 December 2020. Net sales jumped 52.5% to Rs 4,026 crore in Q4 December 2021 from Rs 2,640 crore posted in Q4 December 2020.

Powered by Capital Market – Live News